Bausch + Lomb Corp
TSX:BLCO
Relative Value
The Relative Value of one
BLCO
stock under the Base Case scenario is
60.35
CAD.
Compared to the current market price of 23.42 CAD,
Bausch + Lomb Corp
is
Undervalued by 61%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BLCO Competitors Multiples
Bausch + Lomb Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Bausch + Lomb Corp
TSX:BLCO
|
6B CAD | 1.2 | -19.7 | 19.6 | 92.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.6T JPY | 10.5 | 38.4 | 27.8 | 33.4 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.3B CHF | 3.9 | 38 | 15.7 | 30.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
110.7B DKK | 3.9 | 27.2 | 14.2 | 16.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
14.2B USD | 3.5 | 34.6 | 18.4 | 23.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.1 | 12.9 | 21 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.5B CNY | 9.1 | 25.2 | 22.7 | 22.7 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.2 | 13.8 | 18.7 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.2 | 18.3 | 30.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.9T KRW | 85.2 | -31.2 | -72.4 | -68.5 |